Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Researchers have identified how CBD interacts with cannabinoid receptors to mitigate the negative effects of THC, the psychoactive component of cannabis.

Naloxone is a fantastic tool in reducing opioid deaths, but gentler versions would be helpful for fighting overdose ...

Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population. Researchers have now discovered that opioid delta-receptor agonists may ...

Certain nausea medicines, such as pyridoxine (vitamin B6) and Unisom (doxylamine), are safe to take during pregnancy to help ease morning sickness symptoms.

A new study on brain activity found that heavy cannabis use is linked to reduced activity in memory-related regions, while ...

Scientists have pinpointed a brain circuit that, when activated, reduces anxiety without impairing memory. Using ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

Research indicates that following the onset of an acquired brain injury (ABI), the brain initiates an immediate ...

A network of nerves similar to wires runs all through the human body, from the tips of your fingers and toes, through your ...